Annotated Medicine and Device Lists


Nevirapine (NVP)

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.04. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors Age or weight restriction: > 6 weeks
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Peru 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Haiti. National List of Essential Medicines 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) No observations
Belize. National Drug Formulary 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors No observations

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
FCO X 240
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Guyana. Essential Medicines List. 2020-2021 7.09.02.02. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:18 Antiretroviral Agents No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Suriname. NGK-C-011 6.12 Antiretrovirals No observations
Suriname. NGK-C-011 29.1 Antiretrovirals No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.18.08.16 Non-nucleoside Reverse Transcriptase Inhibitors No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors Age or weight restriction: > 6 weeks
PAHO Strategic Fund Medicine List 2.6.1. Antiretrovirals No observations
Peru 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 60 TABLETA
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations
Guyana. Essential Medicines List. 2020-2021 7.09.02.02. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:18 Antiretroviral Agents No observations
Suriname. NGK-C-011 6.12 Antiretrovirals No observations
Suriname. NGK-C-011 29.1 Antiretrovirals No observations
Haiti. National List of Essential Medicines 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.18.08.16 Non-nucleoside Reverse Transcriptase Inhibitors No observations
Bahamas. Drug Formulary 07.03.01. Anti-Retroviral (ARV) Agents No observations
Belize. National Drug Formulary 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 05.03.02 Non-Nucleoside Reverse Transcriptase Inhibitors Analogues (NNRTIs) No observations

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors Age or weight restriction: > 6 weeks
Haiti. National List of Essential Medicines 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) No observations

Information Resources: Nevirapine (NVP)

Loading ...
Loading ...
Loading ...
No information available